Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Can Google Enhance Drug Safety Surveillance?

Executive Summary

Teleconference between company and FDA signals the Internet search giant may have a way to improve adverse event detection.

Advertisement

Related Content

Califf Lowering FDA Drawbridge To Work With External Expertise
Califf Lowering FDA Drawbridge To Work With External Expertise
PDUFA VI: Breakthrough Issues Among FDA Priorities
PatientsLikeMe Pioneers Social Medicine
FDA Acquires Trove Of Rx Safety Data Through Alliance With PatientsLikeMe
FDA’s Twitter Formula Allows Tweets About Products Without Excessive Risks
Social Media Site Could Help FDA Track Adverse Events
Internet Searching May Get ‘Riskier’ For Patients After FDA Citations

Topics

Advertisement
UsernamePublicRestriction

Register

PS057008

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Add a personalized Question to your Analyst

Cancel